MHR Fund Management’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100,000
Closed -$990K 24
2022
Q3
$990K Hold
100,000
0.19% 8
2022
Q2
$985K Hold
100,000
0.14% 9
2022
Q1
$992K Hold
100,000
0.1% 10
2021
Q4
$1.01M Hold
100,000
0.08% 9
2021
Q3
$1M Hold
100,000
0.11% 11
2021
Q2
$997K Hold
100,000
0.09% 10
2021
Q1
$991K Buy
+100,000
New +$1.01M 0.06% 9

MHR Fund Management's EQHA.U Position: Q4 2022 in Review

MHR Fund Management sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q4 2022, closing a stake of 100,000 shares — an estimated $990K sold.

MHR Fund Management first reported a position in EQHA.U in Q1 2021 and held it in 7 quarters. The position peaked at $1.01M in Q4 2021. 0 funds tracked by Wall St. Rank hold EQHA.U as of Q4 2022.

  • MHR Fund Management reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
  • MHR Fund Management sold 100,000 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q4 2022, an estimated $990K.
  • MHR Fund Management first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and held it in 7 quarters.
  • MHR Fund Management's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $1.01M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q4 2022.

Based on MHR Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.